Sanofi-Aventis signs R&D deal with Turkish university

Sabah - Pharmaceutical company Sanofi-Aventis will cooperate with Turkey’s Ege University for research on new drugs and medications. The R&D deal will transfer more of the French company’s research efforts to Turkey, while the university will benefit from Sanofi-Aventis’ years of experience in drug development.

The long standing partnership between Sanofi-Aventis and Ege University will also help create an innovative environment in Turkey’s healthcare sector. The deal particularly focuses on clinical studies of diabetes, oncology and diseases of cardiovascular and central nervous systems. “Sanofi-Aventis already picked Turkey as a regional R&D base..” said Sanofi-Aventis Turkey Director Olivier Guillaume, adding that the cooperation deal was an important step taken in that direction.

Sanofi-Aventis has over a thousand employees in Turkey and locally produces most of its products in the Turkish market.
Turkey; healthcare sector; pharmaceuticals; drug maker; sanofi-aventis; ege university; r&d; drug research; olivier guillaume